Table 2.
Average Cell Positivity (counts/μm2) on Immunohistochemistry Stainings Summarized as Mean ± SEM.
Control | Bicarbonate | |||||||
---|---|---|---|---|---|---|---|---|
C | BC | cT | cTB | OT | OTB | LT | LTB | |
Tumor edge | ||||||||
CD3 | 0.25 ± 0.06 | 0.16 ± 0.1 | 0.16 ± 0.01 | 0.25 ± 0.1 | 0.42 ± 0.05 | 0.43 ± 0.01 | 0.2 ± 0.1 | 0.25 ± 0.01 |
HLA-DR | 0.57 ± 0.25 | 0.35 ± 0.16 | 0.27 ± 0.09 | 0.39 ± 0.12 | 0.55 ± 0.14 | 0.66 ± 0.09 | 0.48 ± 0.1 | 0.52 ± 0.17 |
CTLA-4 | 1.72 ± 0.17 | 0.49 ± 0.1 | 0.27 ± 0.18 | 0.19 ± 0.16 | 0.22 ± 0.12 | 0.1 ± 0.03 | 0.68 ± 0.15 | 0.64 ± 0.15 |
PD-1 | 0.97 ± 0.1 | 0.48 ± 0.1 | 0.43 ± 0.08 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.21 ± 0.1 | 0.32 ± 0.04 |
PD-L1 | 0.84 ± 0.06 | 0.45 ± 0.04 | 0.21 ± 0.06 | 0.5 ± 0.0 | 0.34 ± 0.1 | 0.35 ± 0.12 | 0.43 ± 0.16 | 0.42 ± 0.03 |
Tumor core | ||||||||
CD3 | 0.37 ± 0.09 | 0.26 ± 0.08 | 0.03 ± 0.02 | 0.26 ± 0.1 | 0.32 ± 0.07 | 0.43 ± 0.01 | 0.33 ± 0.2 | 0.49 ± 0.3 |
HLA-DR | 0.63 ± 0.05 | 0.53 ± 0.07 | 0.29 ± 0.14 | 0.54 ± 0.1 | 0.48 ± 0.08 | 0.7 ± 0.18 | 0.78 ± 0.1 | 1.02 ± 0.27 |
CTLA-4 | 1.78 ± 0.16 | 0.7 ± 0.3 | 0.02 ± 0.0 | 0.15 ± 0.09 | 0.02 ± 0.0 | 0.03 ± 0.02 | 0.6 ± 0.31 | 0.58 ± 0.01 |
PD-1 | 1.3 ± 0.23 | 0.7 ± 0.28 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.5 ± 0.1 | 0.0 ± 0.0 |
PD-L1 | 1.09 ± 0.2 | 1.02 ± 0.21 | 0.3 ± 0.11 | 1.0 ± 0.0 | 0.29 ± 0.09 | 0.54 ± 0.25 | 0.86 ± 0.24 | 0.7 ± 0.1 |
BC = bicarbonate; C = control; cT = conventional transcatheter arterial chemoembolization; CD = cluster of differentiation; cTB = conventional transcatheter arterial chemoembolization + bicarbonate; CTLA-4 = cytotoxic T-lymphocyte–associated protein-4; HLA-DR = human leukocyte antigen DR type; LT = LUMI-bead transcatheter arterial chemoembolization; LTB = LUMI-bead transcatheter arterial chemoembolization + bicarbonate; OT = Oncozene-microsphere transcatheter arterial; OTB = Oncozene-microsphere transcatheter arterial chemoembolization + bicarbonate; PD-1 = programmed cell death protein-1; PD-L1 = programmed cell death protein-1 ligand.